Advertisement

Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study

Published:February 22, 2021DOI:https://doi.org/10.1016/j.jss.2021.01.019

      Abstract

      Background

      Acute kidney injury (AKI) is common after surgery and associated with increased mortality, costs, and lengths of hospitalization. We examined associations between angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB), diuretic, or nonsteroidal anti-inflammatory drug (NSAID) use after major surgery and AKI.

      Materials and methods

      We conducted a nested case-control study of patients who underwent major cardiac, thoracic, general, or vascular surgery in Calgary, Alberta, Canada. Cases with AKI were matched on age, gender, and surgery type with up to five controls without AKI within 30-d after surgery. Adjusted odds ratios (ORs) for AKI were determined based on postoperative administration of ACEIs/ARBs, diuretics, or NSAIDs.

      Results

      Among 33,648 patients in the cohort, 2911 cases with AKI were matched to 9309 controls without AKI. Postoperative diuretic [OR = 1.96; 95% confidence interval (CI) = 1.68-2.29], but not ACEI/ARB (OR = 0.83; 95% CI = 0.72-0.95) or NSAID (OR = 1.12; 95% CI = 0.96-1.31), use was independently associated with higher odds of AKI (including stages 1 and 2/3 AKI) after all types of major surgery. There were increased adjusted odds of AKI 1 to 5 d after first exposure to diuretics and 1 d after first exposure to NSAIDs (but not after later exposures). Relationships between ACEI/ARB use and AKI varied by surgery type (p-interaction = 0.004), with lower odds of AKI observed among ACEI/ARB use after cardiac surgery (OR = 0.70; 95% CI = 0.57-0.81), but no difference after other major surgeries.

      Conclusions

      Postoperative administration of diuretics and NSAIDs was associated with increased odds of AKI after major surgery. These findings characterize potentially modifiable medication exposures associated with AKI after surgery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bihorac A.
        • Yavas S.
        • Subbiah S.
        • et al.
        Long-term risk of mortality and acute kidney injury during hospitalization after major surgery.
        Ann Surg. 2009; 249: 851-858
        • Hobson C.
        • Ozrazgat-Baslanti T.
        • Kuxhausen A.
        • et al.
        Cost and mortality associated with postoperative acute kidney injury.
        Ann Surg. 2015; 261: 1207-1214
        • Hobson C.E.
        • Yavas S.
        • Segal M.S.
        • et al.
        Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.
        Circulation. 2009; 119: 2444-2453
        • Schneider V.
        • Levesque L.E.
        • Zhang B.
        • et al.
        Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis.
        Am J Epidemiol. 2006; 164: 881-889
        • Huerta C.
        • Castellsague J.
        • Varas-Lorenzo C.
        • et al.
        Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.
        Am J Kidney Dis. 2005; 45: 531-539
        • Lee A.
        • Cooper M.G.
        • Craig J.C.
        • et al.
        Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function.
        Cochrane Database Syst Rev. 2007; : CD002765
        • Bainbridge D.
        • Cheng D.C.
        • Martin J.E.
        • et al.
        NSAID-analgesia, pain control and morbidity in cardiothoracic surgery.
        Can J Anaesth. 2006; 53: 46-59
        • Arora P.
        • Rajagopalam S.
        • Ranjan R.
        • et al.
        Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.
        Clin J Am Soc Nephrol. 2008; 3: 1266-1273
        • Coca S.G.
        • Garg A.X.
        • Swaminathan M.
        • et al.
        Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
        Nephrol Dial Transplant. 2013; 28: 2787-2799
        • Benedetto U.
        • Sciarretta S.
        • Roscitano A.
        • et al.
        Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
        Ann Thorac Surg. 2008; 86: 1160-1165
        • Shah M.
        • Jain A.K.
        • Brunelli S.M.
        • et al.
        Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis.
        BMC Nephrol. 2014; 15: 53
        • Miceli A.
        • Capoun R.
        • Fino C.
        • et al.
        Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.
        J Am Coll Cardiol. 2009; 54: 1778-1784
        • Zhang Y.
        • Ma L.
        Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery.
        Eur J Cardiothorac Surg. 2015; 47: 788-795
        • Bandeali S.J.
        • Kayani W.T.
        • Lee V.V.
        • et al.
        Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery.
        Cardiovasc Ther. 2013; 31: 291-297
        • Bandeali S.J.
        • Kayani W.T.
        • Lee V.V.
        • et al.
        Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting.
        Am J Cardiol. 2012; 110: 919-923
        • Drenger B.
        • Fontes M.L.
        • Miao Y.
        • et al.
        Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.
        Circulation. 2012; 126: 261-269
        • Ouzounian M.
        • Buth K.J.
        • Valeeva L.
        • et al.
        Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery.
        Ann Thorac Surg. 2012; 93: 559-564
        • Gandhi A.
        • Husain M.
        • Salhiyyah K.
        • et al.
        Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients?.
        Interact Cardiovasc Thorac Surg. 2012; 15: 750-755
        • Lassnigg A.
        • Donner E.
        • Grubhofer G.
        • et al.
        Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.
        J Am Soc Nephrol. 2000; 11: 97-104
        • Parolari A.
        • Pesce L.L.
        • Pacini D.
        • et al.
        Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management.
        Ann Thorac Surg. 2012; 93: 584-591
        • Patel N.N.
        • Rogers C.A.
        • Angelini G.D.
        • et al.
        Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review.
        Heart Fail Rev. 2011; 16: 553-567
        • von Elm E.
        • Altman D.G.
        • Egger M.
        • et al.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
        J Clin Epidemiol. 2008; 61: 344-349
        • Benchimol E.I.
        • Smeeth L.
        • Guttmann A.
        • et al.
        The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.
        PLoS Med. 2015; 12: e1001885
        • Redelmeier D.
        • Scales D.
        • Kopp A.
        Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.
        BMJ. 2005; 331: 932
        • Siddiqui N.F.
        • Coca S.G.
        • Devereaux P.J.
        • et al.
        Secular trends in acute dialysis after elective major surgery--1995 to 2009.
        CMAJ. 2012; 184: 1237-1245
        • Small R.G.
        • Witt R.E.
        Major and minor surgery.
        JAMA. 1965; 191: 180-182
        • Earl R.
        Definition of major and minor surgery: a question and an answer.
        Ann Surg. 1917; 65: 799
        • Hemmelgarn B.R.
        • Clement F.
        • Manns B.J.
        • et al.
        Overview of the Alberta kidney disease Network.
        BMC Nephrol. 2009; 10: 30
        • Austin P.C.
        • Daly P.A.
        • Tu J.V.
        A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario.
        Am Heart J. 2002; 144: 290-296
        • Hux J.E.
        • Ivis F.
        • Flintoft V.
        • et al.
        Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.
        Diabetes Care. 2002; 25: 512-516
        • Kokotailo R.A.
        • Hill M.D.
        Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.
        Stroke. 2005; 36: 1776-1781
        • Lee D.S.
        • Donovan L.
        • Austin P.C.
        • et al.
        Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research.
        Med Care. 2005; 43: 182-188
        • Quan H.
        • Khan N.
        • Hemmelgarn B.R.
        • et al.
        Validation of a case definition to define hypertension using administrative data.
        Hypertension. 2009; 54: 1423-1428
        • Clement F.M.
        • James M.T.
        • Chin R.
        • et al.
        Validation of a case definition to define chronic dialysis using outpatient administrative data.
        BMC Med Res Methodol. 2011; 11: 25
      1. KDIGO clinical practice guideline for acute kidney injury.
        Kidney Int. 2012; 2: 124-138
        • Levesque L.E.
        • Hanley J.A.
        • Kezouh A.
        • et al.
        Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.
        BMJ. 2010; 340: b5087
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • James M.T.
        • Hemmelgarn B.R.
        • Wiebe N.
        • et al.
        Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study.
        Lancet. 2010; 376: 2096-2103
        • Quan H.
        • Sundararajan V.
        • Halfon P.
        • et al.
        Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
        Med Care. 2005; 43: 1130-1139
        • Vittinghoff E.
        • Glidden D.V.
        • Shiboski S.C.
        • et al.
        Regression methods in biostatistics: linear, logistic, survival, and repeated measures models.
        2nd ed. Springer Science+Business Media, New York, NY2012
        • Niven D.J.
        • Berthiaume L.R.
        • Fick G.H.
        • et al.
        Matched case-control studies: a review of reported statistical methodology.
        Clin Epidemiol. 2012; 4: 99-110
        • Lim E.
        • Ali Z.A.
        • Attaran R.
        • et al.
        Evaluating routine diuretics after coronary surgery: a prospective randomized controlled trial.
        Ann Thorac Surg. 2002; 73: 153-155
        • Mahesh B.
        • Yim B.
        • Robson D.
        • et al.
        Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
        Eur J Cardiothorac Surg. 2008; 33: 370-376
        • Yallop K.G.
        • Sheppard S.V.
        • Smith D.C.
        The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine.
        Anaesthesia. 2008; 63: 576-582
        • Yoo Y.C.
        • Youn Y.-N.
        • Shim J.K.
        • et al.
        Effects of renin-angiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting.
        Circ J. 2010; 74: 1852-1858